| View |
|
BRP-066-04
|
Insulin Human (rDNA)
|
Insunova-R
|
100 IU/mL
|
Solution for Injection (IM/SC)
|
Antidiabetics
|
M.J. Biopharm Pvt., Ltd.
|
India
|
CLIDP Conversion
|
20 January 2023
|
05 June 2026
|
| View |
|
DRP-5403-18
|
Azithromycin (as dihydrate)
|
Azithrocirc
|
500 mg
|
Film-Coated Tablet
|
Antibacterial (Macrolide)
|
Magbro Healthcare Pvt. Ltd.
|
India
|
Renewal
|
23 June 2024
|
23 July 2029
|
| View |
|
DRP-5487-02
|
Etoricoxib
|
Akticib
|
90 mg
|
Film-Coated Tablet
|
Selective COX-2 Inhibitor
|
Zim Laboratories Ltd
|
India
|
Renewal
|
21 March 2024
|
27 August 2029
|
| View |
|
DRP-7357-07
|
Cefixime (as trihydrate)
|
Hilcef 400
|
400 mg
|
Dispersible Tablet
|
Antibacterial (Cephalosporin)
|
Swiss Pharma Pvt. Ltd.
|
India
|
Renewal
|
29 March 2024
|
26 February 2029
|
| View |
|
BRP-066-03
|
Insulin Human (rDNA)
|
Insuljack R
|
100 IU/mL
|
Solution for Injection (IM/SC)
|
Antidiabetics
|
M.J. Biopharm Pvt., Ltd
|
India
|
CLIDP Conversion
|
19 January 2023
|
05 June 2026
|
| View |
|
DRP-4961-22
|
Cefixime (as trihydrate)
|
Soniceph
|
100 mg/5 mL
|
Powder for Suspension
|
Antibacterial (Cephalosporin)
|
Sakar Healthcare Pvt. Ltd
|
India
|
CLIDP Conversion
|
19 January 2023
|
27 November 2028
|
| View |
|
DRP-5493-03
|
Etoricoxib
|
K-Tori
|
120 mg
|
Film-Coated Tablet
|
Non-Steroidal Anti-Inflammatory Drug/NSAID (Coxib)
|
XL Laboratories Pvt. Ltd
|
India
|
Renewal
|
27 March 2024
|
28 August 2029
|
| View |
|
DRP-5683-21
|
CEFIXIME
|
ZERRIOXIME
|
20 mg/mL
|
Granules for Suspension (Oral Drops)
|
ANTIBACTERIAL (CEPHALOSPORIN)
|
J.M. Tolmann Laboratories Inc.
|
Philippines
|
Renewal
|
18 February 2024
|
20 February 2029
|
| View |
|
DRP-9296-01
|
Loratadine
|
Allos
|
5 mg/ 5 mL
|
Syrup
|
Antihistamine
|
Enicar Pharmaceuticals Pvt. Ltd.
|
India
|
CLIDP Conversion
|
19 January 2023
|
16 November 2025
|
| View |
|
DRP-9424-01
|
Carbocisteine
|
Tussis-50
|
50 mg/mL
|
Syrup (Oral Drops)
|
Mucolytic
|
Enicar Pharmaceuticals Pvt. Ltd
|
India
|
CLIDP Conversion
|
19 January 2023
|
29 December 2025
|
| View |
|
DRP-9566-01
|
Paracetamol
|
Pyrexia 125
|
125 mg/5 mL
|
Suspension
|
Analgesic/Antipyretic
|
Enicar Pharmaceuticals Pvt. Ltd
|
India
|
CLIDP Conversion
|
19 January 2023
|
26 February 2026
|
| View |
|
DR-XY38420
|
Methylergometrine (As Maleate)
|
Utergin
|
200 mcg/mL
|
Solution For Injection (Im/Iv)
|
-
|
Oboi Laboratories
|
India
|
Automatic Renewal
|
23 September 2020
|
31 August 2025
|
| View |
|
DRP-9569-01
|
Paracetamol
|
Pyrexia 250
|
250 mg/5 mL
|
Suspension
|
Analgesic/Antipyretic
|
Enicar Pharmaceuticals Pvt. Ltd.
|
India
|
CLIDP Conversion
|
19 January 2023
|
26 February 2026
|
| View |
|
DRP-9607-01
|
Carbocisteine
|
Tussis-200
|
200 mg/5 mL
|
Syrup
|
Mucolytic
|
Enicar Pharmaceuticals Pvt. Ltd
|
India
|
CLIDP Conversion
|
19 January 2023
|
24 March 2026
|
| View |
|
DRP-10246-05
|
Ceftriaxone (as sodium)
|
Gioxone
|
1 g
|
Powder for Injection (IM/IV)
|
Antibacterial (Third-Generation Cephalosporin)
|
Theon Pharmaceuticals Limited
|
India
|
CLIDP Conversion
|
19 January 2023
|
01 October 2026
|
| View |
|
DRP-10626-02
|
Rocuronium Bromide
|
Goconium IV
|
10mg/mL
|
Solution for Injection (IV)
|
Muscle Relaxant
|
Immacule Lifesciences Private Limited
|
India
|
CLIDP Conversion
|
19 January 2023
|
03 November 2026
|
| View |
|
DRP-12602-01
|
Paclitaxel
|
Paxikem
|
6 mg/mL (100 mg/ 16. 7 mL)
|
Solution for Injection (IV Infusion)
|
Antineoplastic Agent (Taxane)
|
Eskayef Pharmaceuticals Limited-Rupganj Plant
|
Bangladesh
|
CLIDP Conversion
|
19 January 2023
|
13 September 2027
|
| View |
|
DRP-13073-01
|
Epirubicin Hydrochloride
|
Epirub-50
|
50 mg
|
Lyophilized Powder for Injection (IV)
|
Antineoplastic
|
Bruck Pharma Private Limited
|
India
|
CLIDP Conversion
|
19 January 2023
|
25 November 2027
|
| View |
|
DRP-8584-16
|
Pantoprazole (as sodium sesquihydrate) + Domperidone
|
Gopadome
|
40 mg/30 mg
|
Modified-Release Capsule
|
-
|
Theon Pharmaceuticals Limited
|
India
|
CLIDP Conversion
|
17 January 2023
|
18 December 2024
|
| View |
|
DRP-9638-04
|
Piperacillin (as sodium) + Tazobactam (as sodium)
|
Berazoba-2.25
|
2g/250mg
|
Powder for IV Infusion
|
-
|
Injectcare Parenterals Pvt. Ltd.
|
India
|
CLIDP Conversion
|
17 January 2023
|
23 April 2026
|